secwatch.observer — SEC 8-K summary
======================================

Issuer:     Allogene Therapeutics, Inc. (ALLO)
CIK:        0001737287
Form:       8-K
Filed at:   2021-08-02T23:59:59+00:00
Accession:  0001737287-21-000034
Event type: leadership
Sentiment:  neutral
Materiality: 0.60
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Allogene Therapeutics expands board to 11, appoints Elizabeth Barrett and Vicki Sato as directors
--------------------------------------------------------------------------------

- Board increased from 9 to 11; Barrett (Class I) and Dr. Sato (Class II) appointed effective July 30, 2021.
- Barrett receives annual retainer of $40,000 and option grant with $850,000 grant date value vesting over 3 years.
- Dr. Sato receives $40,000 retainer, option grant of $425,000 value (3-year vest), and RSU award of $425,000 value (3 annual installments).
- Both directors enter indemnification agreements; equity grants accelerate on change of control.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1737287/000173728721000034/0001737287-21-000034-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1737287/000173728721000034/allo-20210730.htm
  HTML page:      https://secwatch.observer/filing/0001737287-21-000034

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer